Kiromic Biopharma, Inc.·4

Jun 4, 5:13 PM ET

Ralston Shannon 4

4 · Kiromic Biopharma, Inc. · Filed Jun 4, 2024

Insider Transaction Report

Form 4
Period: 2024-06-03
Transactions
  • Purchase

    $2,000,000 Senior Secured Convertible Note

    2024-06-03$2000000.00/sh(indirect: see footnote)
    Exercise: $2.50From: 2024-06-03Exp: 2025-06-03Common Stock (800,000 underlying)
Footnotes (3)
  • [F1]The$2,000,000 Senior Secured Convertible Note bears interest at 25% and is subject to a 19.99% blocker.
  • [F2]The Reporting Person beneficially owns an aggregate $19,239,703 principal amount Senior Secured Convertible Notes.
  • [F3]Through S.hield Cap1tal Funding LLC.

Documents

1 file
  • 4
    tm2416365-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT